SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,482,000 | -5.6% | 75,000 | 0.0% | 0.02% | -8.3% |
| Q1 2019 | $2,628,000 | -30.4% | 75,000 | 0.0% | 0.02% | -25.0% |
| Q3 2018 | $3,776,000 | -74.8% | 75,000 | -70.0% | 0.03% | -64.4% |
| Q2 2018 | $14,963,000 | +18.8% | 250,000 | -9.1% | 0.09% | -29.1% |
| Q1 2018 | $12,595,000 | +58.0% | 275,000 | +37.5% | 0.13% | +54.9% |
| Q4 2017 | $7,970,000 | -41.2% | 200,000 | -41.0% | 0.08% | -46.4% |
| Q3 2017 | $13,558,000 | +162.1% | 338,956 | +182.5% | 0.15% | +118.6% |
| Q2 2017 | $5,172,000 | -68.5% | 120,000 | -77.1% | 0.07% | -71.5% |
| Q1 2017 | $16,433,000 | +319.9% | 525,000 | +238.7% | 0.25% | +296.8% |
| Q4 2016 | $3,914,000 | +104.2% | 155,000 | +100.0% | 0.06% | +87.9% |
| Q3 2016 | $1,917,000 | -14.8% | 77,500 | -29.9% | 0.03% | -21.4% |
| Q2 2016 | $2,251,000 | +20.9% | 110,525 | -9.5% | 0.04% | +20.0% |
| Q1 2016 | $1,862,000 | +30.7% | 122,086 | +15.2% | 0.04% | +34.6% |
| Q4 2015 | $1,425,000 | -34.5% | 106,021 | -31.6% | 0.03% | -40.9% |
| Q3 2015 | $2,174,000 | -9.2% | 154,943 | +9.8% | 0.04% | -4.3% |
| Q2 2015 | $2,395,000 | +77.4% | 141,074 | +26.3% | 0.05% | +76.9% |
| Q1 2015 | $1,350,000 | +401.9% | 111,673 | +244.4% | 0.03% | +420.0% |
| Q4 2014 | $269,000 | – | 32,428 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |